Merck Sharp and Dohme Corp. and Ors. Vs. SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited (hereinafter “SMS Pharma”) had filed an application to modify an ex-parte ad interim order passed by the Hon’ble Delhi High Court in favour of Merck Sharp and Dohme Corp. (hereinafter “Merck”) in a suit for infringement of Merck’s Indian patent no. 209816.
0 Comments
July 27, 2021